Historically, there has been a scarcity of evidence-based topical therapy to hasten the
healing of diabetic foot ulcers. But recently new evidence-based treatments have emerged …

Diabetic foot is a serious complication of diabetes which aggravates the patient's condition
whilst also having significant socioeconomic impact. The aim of the present review is to …

Situations where normal autografts cannot be used to replace damaged skin often lead to a
greater risk of mortality, prolonged hospital stay and increased expenditure for the National …

Tissue-engineered skin is now a reality. For patients with extensive full-thickness burns,
laboratory expansion of skin cells to achieve barrier function can make the difference …

Healing a wound is a process that comprises sequential steps aimed to restore the structure
and function of damaged cells and tissues. Since the antiquity, to promote an effective …

Bioprinted s kin tissue has the potential for aiding drug screening, formulation development,
clinical transplantation, chemical and cosmetic testing, as well as basic research. Limitations …

Skin is the largest organ of human body, acting as a barrier with protective, immunologic and
sensorial functions. Its permanent exposure to the external environment can result in …

The engineering of skin substitutes and their application on human patients has become a
reality. However, cell biologists, biochemists, technical engineers, and surgeons are still …

Tissue-engineered skin has been in clinical use for 25 years and has developed greatly
during this time. This review looks at the role biomaterials need to play in providing for …

Diabetic foot ulcer (DFU) is one of the most severe complications of diabetes mellitus, often
resulting in a limb amputation. A cell-based therapy is a highly promising approach for an …